PAVmed Inc. (PAVM)
NASDAQ: PAVM · IEX Real-Time Price · USD
1.010
-0.030 (-2.88%)
At close: Jul 19, 2024, 4:00 PM
1.080
+0.070 (6.93%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
PAVmed Market Cap
PAVmed has a market cap or net worth of $9.53 million as of July 22, 2024. Its market cap has decreased by -76.30% in one year.
Market Cap
9.53M
Enterprise Value
33.68M
1-Year Change
-76.30%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $9.53M, a decrease of -94.49%. That is a compound annual growth rate of -30.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 9.50M | -71.39% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 9.97M |
| ABVC BioPharma | 9.95M |
| Plus Therapeutics | 9.93M |
| Tonix Pharmaceuticals Holding | 9.78M |
| Pieris Pharmaceuticals | 9.57M |
| Elevai Labs | 9.44M |
| Mangoceuticals | 9.43M |
| Nexalin Technology | 9.41M |